{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T12:49:37Z","timestamp":1761569377147,"version":"build-2065373602"},"reference-count":56,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinical-genitourinary-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Genitourinary Cancer"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/j.clgc.2023.03.008","type":"journal-article","created":{"date-parts":[[2023,3,23]],"date-time":"2023-03-23T22:07:30Z","timestamp":1679609250000},"page":"393-402.e5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Expression of RSUME is Associated With Poor Prognosis in Clear Cell Renal Carcinoma: Involvement of ROS Related Metabolism"],"prefix":"10.1016","volume":"21","author":[{"given":"David","family":"Gonilski-Pacin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Ciancio del Giudice","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2628-4358","authenticated-orcid":false,"given":"Belen","family":"Elguero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eduardo","family":"Arzt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clgc.2023.03.008_bib0001","unstructured":"The Global Cancer Observatory (GCO). Available at: https:\/\/gco.iarc.fr\/. Accessed March 21, 2022."},{"key":"10.1016\/j.clgc.2023.03.008_bib0002","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1097\/00000478-200305000-00005","article-title":"Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma","volume":"27","author":"Cheville","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.clgc.2023.03.008_bib0003","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.cell.2018.03.043","article-title":"Deterministic evolutionary trajectories influence primary tumor growth: TRACERx Renal","volume":"173","author":"Turajlic","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.clgc.2023.03.008_bib0004","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/35017054","article-title":"Ubiquitination of hypoxia-inducible factor requires direct binding to the \u03b2-domain of the von Hippel\u2013Lindau protein","volume":"2","author":"Ohh","year":"2000","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.clgc.2023.03.008_bib0005","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1038\/nrc2502","article-title":"The von Hippel\u2013Lindau tumour suppressor protein: O2 sensing and cancer","volume":"8","author":"Kaelin Jr","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.clgc.2023.03.008_bib0006","doi-asserted-by":"crossref","first-page":"F1","DOI":"10.1152\/ajprenal.00424.2003","article-title":"The role of von Hippel-Lindau tumor suppressor protein and hypoxia in renal clear cell carcinoma","volume":"287","author":"Sufan","year":"2004","journal-title":"Am J physiol. Renal physiol."},{"key":"10.1016\/j.clgc.2023.03.008_bib0007","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1146\/annurev-cancerbio-030617-050527","article-title":"The von Hippel\u2013Lindau Tumor Suppressor Protein","volume":"2","author":"Kaelin","year":"2018","journal-title":"Ann Rev Cancer Biol"},{"key":"10.1016\/j.clgc.2023.03.008_bib0008","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/nrc1187","article-title":"Targeting HIF-1 for cancer therapy","volume":"3","author":"Semenza","year":"2003","journal-title":"Nat Rev Cancer."},{"key":"10.1016\/j.clgc.2023.03.008_bib0009","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1152\/jappl.2000.88.5.1880","article-title":"Cellular oxygen sensing by mitochondria: old questions, new insight","volume":"88","author":"Chandel","year":"2000","journal-title":"J Appl Physiol (1985)"},{"key":"10.1016\/j.clgc.2023.03.008_bib0010","doi-asserted-by":"crossref","first-page":"11619","DOI":"10.1074\/jbc.273.19.11619","article-title":"Intracellular signaling by reactive oxygen species during hypoxia in cardiomyocytes","volume":"273","author":"Duranteau","year":"1998","journal-title":"J Biol Chem"},{"key":"10.1016\/j.clgc.2023.03.008_bib0011","doi-asserted-by":"crossref","first-page":"11715","DOI":"10.1073\/pnas.95.20.11715","article-title":"Mitochondrial reactive oxygen species trigger hypoxia-induced transcription","volume":"95","author":"Chandel","year":"1998","journal-title":"Proc Nat Acad Sci USA"},{"key":"10.1016\/j.clgc.2023.03.008_bib0012","doi-asserted-by":"crossref","first-page":"C227","DOI":"10.1152\/ajpcell.00112.2001","article-title":"Reactive species mechanisms of cellular hypoxia-reoxygenation injury","volume":"282","author":"Li","year":"2002","journal-title":"Am J physiol Cell physiol"},{"key":"10.1016\/j.clgc.2023.03.008_bib0013","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1161\/01.ATV.0000012262.76205.6A","article-title":"Role of mitochondrial oxidant generation in endothelial cell responses to hypoxia","volume":"22","author":"Pearlstein","year":"2002","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.clgc.2023.03.008_bib0014","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/j.1432-1033.1995.092_c.x","article-title":"Diphenylene iodonium inhibits the induction of erythropoietin and other mammalian genes by hypoxia. Implications for the mechanism of oxygen sensing","volume":"234","author":"Gleadle","year":"1995","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.clgc.2023.03.008_bib0015","doi-asserted-by":"crossref","first-page":"8019","DOI":"10.1074\/jbc.M611569200","article-title":"NAD (P) H oxidases regulate HIF-2\u03b1 protein expression","volume":"282","author":"Block","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/j.clgc.2023.03.008_bib0016","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.freeradbiomed.2004.02.071","article-title":"Upregulation of NAD(P)H oxidase 1 in hypoxia activates hypoxia-inducible factor 1 via increase in reactive oxygen species","volume":"36","author":"Goyal","year":"2004","journal-title":"Free Radical Biol Med"},{"key":"10.1016\/j.clgc.2023.03.008_bib0017","doi-asserted-by":"crossref","first-page":"4459","DOI":"10.1007\/s00018-020-03536-5","article-title":"The multifaceted role of reactive oxygen species in tumorigenesis","volume":"77","author":"Kirtonia","year":"2020","journal-title":"Cell Mole Life Sci: CMLS"},{"key":"10.1016\/j.clgc.2023.03.008_bib0018","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.581197","article-title":"Characterization of ROS metabolic equilibrium reclassifies pan-cancer samples and guides pathway targeting therapy","volume":"10","author":"Shen","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.clgc.2023.03.008_bib0019","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.cell.2007.07.044","article-title":"RSUME, a small RWD-containing protein, enhances SUMO conjugation and stabilizes HIF-1\u03b1 during hypoxia","volume":"131","author":"Carbia-Nagashima","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.clgc.2023.03.008_bib0020","first-page":"16","article-title":"The relationship between RSUME and VHL\/HIF-1\u03b1 signalling pathway in renal cell carcinoma","author":"Wang","year":"2020","journal-title":"Arch Med Sci"},{"key":"10.1016\/j.clgc.2023.03.008_bib0021","doi-asserted-by":"crossref","first-page":"4855","DOI":"10.1038\/onc.2014.407","article-title":"RSUME inhibits VHL and regulates its tumor suppressor function","volume":"34","author":"Gerez","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.clgc.2023.03.008_bib0022","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41419-019-1507-3","article-title":"von Hippel-Lindau mutants in renal cell carcinoma are regulated by increased expression of RSUME","volume":"10","author":"Tedesco","year":"2019","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.clgc.2023.03.008_bib0023","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1530\/ERC-11-0211","article-title":"RSUME is implicated in HIF-1-induced VEGF-A production in pituitary tumour cells","volume":"19","author":"Shan","year":"2012","journal-title":"Endocr-related cancer"},{"key":"10.1016\/j.clgc.2023.03.008_bib0024","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.gene.2016.12.012","article-title":"Relationship between RSUME and HIF-1\u03b1\/VEGF-A with invasion of pituitary adenoma","volume":"603","author":"He","year":"2017","journal-title":"Gene"},{"key":"10.1016\/j.clgc.2023.03.008_bib0025","unstructured":"The human protein Atlas. Available at: https:\/\/www.proteinatlas.org\/ENSG00000122481-RWDD3\/pathology\/renal+cancer\/KIRC. Accessed January 10, 2022."},{"key":"10.1016\/j.clgc.2023.03.008_bib0026","doi-asserted-by":"crossref","first-page":"548","DOI":"10.3390\/cancers13030548","article-title":"Identification of RCC subtype-specific microRNAs\u2013meta-analysis of high-throughput RCC tumor microRNA expression data","volume":"13","author":"Kajdasz","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.clgc.2023.03.008_bib0027","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.7150\/jca.12145","article-title":"Potential approaches and recent advances in biomarker discovery in clear-cell renal cell carcinoma","volume":"6","author":"Majer","year":"2015","journal-title":"J Cancer"},{"year":"2012","series-title":"The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data","author":"Cerami","key":"10.1016\/j.clgc.2023.03.008_bib0028"},{"key":"10.1016\/j.clgc.2023.03.008_bib0029","doi-asserted-by":"crossref","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal","volume":"6","author":"Gao","year":"2013","journal-title":"Sci Signal."},{"key":"10.1016\/j.clgc.2023.03.008_bib0030","doi-asserted-by":"crossref","first-page":"R80","DOI":"10.1186\/gb-2004-5-10-r80","article-title":"Bioconductor: open software development for computational biology and bioinformatics","volume":"5","author":"Gentleman","year":"2004","journal-title":"Genome Biol"},{"key":"10.1016\/j.clgc.2023.03.008_bib0031","unstructured":"cBioPortal for Cancer Genomics. Available at: https:\/\/www.cbioportal.org\/. Accessed May 21, 2022."},{"key":"10.1016\/j.clgc.2023.03.008_bib0032","unstructured":"UCSC (University of California Santa Cruz) Xena. http:\/\/xena.ucsc.edu\/. Accessed May 21, 2022."},{"key":"10.1016\/j.clgc.2023.03.008_bib0033","doi-asserted-by":"crossref","DOI":"10.1093\/database\/bau092","article-title":"Renal Gene Expression Database (RGED): a relational database of gene expression profiles in kidney disease","volume":"2014","author":"Zhang","year":"2014","journal-title":"Database: J Biol Databases Curat"},{"key":"10.1016\/j.clgc.2023.03.008_bib0034","unstructured":"Gene expression omnibus. https:\/\/www.ncbi.nlm.nih.gov\/geo\/. Accessed May 21, 2022."},{"key":"10.1016\/j.clgc.2023.03.008_bib0035","doi-asserted-by":"crossref","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles","volume":"102","author":"Subramanian","year":"2005","journal-title":"Proc Nat Acad Sci USA"},{"key":"10.1016\/j.clgc.2023.03.008_bib0036","unstructured":"Gene set enrichment analysis web. http:\/\/software.broadinstitute.org\/gsea\/index.jsp. Accessed January 10, 2022."},{"key":"10.1016\/j.clgc.2023.03.008_bib0037","unstructured":"Gene set enrichment analysis user guide. https:\/\/www.gsea-msigdb.org\/gsea\/doc\/GSEAUserGuideFrame.html. Accessed June 15, 2022."},{"issue":"1","key":"10.1016\/j.clgc.2023.03.008_bib0038","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1021\/acs.jproteome.0c00655","article-title":"Mass spectrometry-based metabolic fingerprinting contributes to unveil the role of RSUME in renal cell carcinoma cell metabolism","volume":"20","author":"Martinefski","year":"2020","journal-title":"J Proteome Res"},{"key":"10.1016\/j.clgc.2023.03.008_bib0039","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000012258","article-title":"Association of SUMOlation pathway genes with stroke in a genome-wide association study in India","author":"Kumar","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.clgc.2023.03.008_bib0040","doi-asserted-by":"crossref","first-page":"5794","DOI":"10.1200\/JCO.2008.21.4809","article-title":"Prognostic factors for overall survival in patients with metastatic renal cell carcinoma treated with vascular endothelial growth factor\u2013targeted agents: results from a large, multicenter study","volume":"27","author":"Heng","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clgc.2023.03.008_bib0041","article-title":"The association of platelet count with clinicopathological significance and prognosis in renal cell carcinoma: a systematic review and meta-analysis","volume":"10","author":"Gu","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.clgc.2023.03.008_bib0042","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000106322","article-title":"Clinical significance of platelet count in patients with renal cell carcinoma","volume":"79","author":"Erdemir","year":"2007","journal-title":"Urol Int"},{"key":"10.1016\/j.clgc.2023.03.008_bib0043","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1046\/j.1464-410x.2000.00792.x","article-title":"Poor prognosis associated with thrombocytosis in patients with renal cell carcinoma","volume":"86","author":"Symbas","year":"2000","journal-title":"BJU Int"},{"key":"10.1016\/j.clgc.2023.03.008_bib0044","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1002\/cam4.270","article-title":"Tumor signatures of PTHLH overexpression, high serum calcium, and poor prognosis were observed exclusively in clear cell but not non clear cell renal carcinomas","volume":"3","author":"Yao","year":"2014","journal-title":"Cancer Med"},{"key":"10.1016\/j.clgc.2023.03.008_bib0045","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1200\/JCO.2004.06.132","article-title":"Prognostic factors for survival in previously treated patients with metastatic renal cell carcinoma","volume":"22","author":"Motzer","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clgc.2023.03.008_bib0046","doi-asserted-by":"crossref","first-page":"2530","DOI":"10.1200\/JCO.1999.17.8.2530","article-title":"Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma","volume":"17","author":"Motzer","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clgc.2023.03.008_bib0047","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1038\/nrneph.2015.46","article-title":"The hallmarks of cancer: relevance to the pathogenesis of polycystic kidney disease","volume":"11","author":"Seeger-Nukpezah","year":"2015","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.clgc.2023.03.008_bib0048","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1038\/35050128","article-title":"Co-assembly of polycystin-1 and -2 produces unique cation-permeable currents","volume":"408","author":"Hanaoka","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.clgc.2023.03.008_bib0049","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/ncb754","article-title":"Polycystin-2 is an intracellular calcium release channel","volume":"4","author":"Koulen","year":"2002","journal-title":"Nat Cell Biol"},{"key":"10.1016\/j.clgc.2023.03.008_bib0050","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1038\/nrm2278","article-title":"When cilia go bad: cilia defects and ciliopathies","volume":"8","author":"Fliegauf","year":"2007","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.clgc.2023.03.008_bib0051","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.semnephrol.2019.12.002","article-title":"Reprogramming of metabolism in kidney cancer","volume":"40","author":"Wettersten","year":"2020","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.clgc.2023.03.008_bib0052","doi-asserted-by":"crossref","first-page":"509","DOI":"10.3390\/metabo10120509","article-title":"Integration of Lipidomics and transcriptomics reveals reprogramming of the lipid metabolism and composition in clear cell renal cell carcinoma","volume":"10","author":"Lucarelli","year":"2020","journal-title":"Metabolites"},{"key":"10.1016\/j.clgc.2023.03.008_bib0053","doi-asserted-by":"crossref","first-page":"6599","DOI":"10.7150\/jca.33024","article-title":"The mRNA expression signature and prognostic analysis of multiple fatty acid metabolic enzymes in clear cell renal cell carcinoma","volume":"10","author":"Zhao","year":"2019","journal-title":"J Cancer"},{"key":"10.1016\/j.clgc.2023.03.008_bib0054","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.redox.2017.08.021","article-title":"Regulation of platelet activation and thrombus formation by reactive oxygen species","volume":"14","author":"Qiao","year":"2018","journal-title":"Redox Biol"},{"key":"10.1016\/j.clgc.2023.03.008_bib0055","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1042\/BST20120327","article-title":"Platelet mitochondrial function: from regulation of thrombosis to biomarker of disease","volume":"41","author":"Zharikov","year":"2013","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/j.clgc.2023.03.008_bib0056","doi-asserted-by":"crossref","first-page":"e722","DOI":"10.1038\/cddis.2013.253","article-title":"ROS-mediated platelet generation: a microenvironment-dependent manner for megakaryocyte proliferation, differentiation, and maturation","volume":"4","author":"Chen","year":"2013","journal-title":"Cell Death Dis"}],"container-title":["Clinical Genitourinary Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767323000678?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1558767323000678?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T11:37:31Z","timestamp":1761565051000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1558767323000678"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":56,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S1558767323000678"],"URL":"https:\/\/doi.org\/10.1016\/j.clgc.2023.03.008","relation":{},"ISSN":["1558-7673"],"issn-type":[{"type":"print","value":"1558-7673"}],"subject":[],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expression of RSUME is Associated With Poor Prognosis in Clear Cell Renal Carcinoma: Involvement of ROS Related Metabolism","name":"articletitle","label":"Article Title"},{"value":"Clinical Genitourinary Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clgc.2023.03.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}